1 Introduction to Research & Analysis Reports
1.1 Adult Attention Deficit and Hyperactivity Disorder Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adult Attention Deficit and Hyperactivity Disorder Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adult Attention Deficit and Hyperactivity Disorder Overall Market Size
2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size: 2022 VS 2029
2.2 Global Adult Attention Deficit and Hyperactivity Disorder Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adult Attention Deficit and Hyperactivity Disorder Players in Global Market
3.2 Top Global Adult Attention Deficit and Hyperactivity Disorder Companies Ranked by Revenue
3.3 Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Companies
3.4 Top 3 and Top 5 Adult Attention Deficit and Hyperactivity Disorder Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adult Attention Deficit and Hyperactivity Disorder Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adult Attention Deficit and Hyperactivity Disorder Players in Global Market
3.6.1 List of Global Tier 1 Adult Attention Deficit and Hyperactivity Disorder Companies
3.6.2 List of Global Tier 2 and Tier 3 Adult Attention Deficit and Hyperactivity Disorder Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Adult Attention Deficit and Hyperactivity Disorder Market Size Markets, 2022 & 2029
4.1.2 Stimulant
4.1.3 Non-stimulant
4.2 By Type – Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
4.2.1 By Type – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2023
4.2.2 By Type – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2024-2029
4.2.3 By Type – Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adult Attention Deficit and Hyperactivity Disorder Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
5.2.1 By Application – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2023
5.2.2 By Application – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2024-2029
5.2.3 By Application – Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Adult Attention Deficit and Hyperactivity Disorder Market Size, 2022 & 2029
6.2 By Region – Global Adult Attention Deficit and Hyperactivity Disorder Revenue & Forecasts
6.2.1 By Region – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2023
6.2.2 By Region – Global Adult Attention Deficit and Hyperactivity Disorder Revenue, 2024-2029
6.2.3 By Region – Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2029
6.3.2 US Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.3.3 Canada Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.3.4 Mexico Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2029
6.4.2 Germany Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.3 France Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.4 U.K. Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.5 Italy Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.6 Russia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.7 Nordic Countries Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.4.8 Benelux Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2029
6.5.2 China Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.5.3 Japan Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.5.4 South Korea Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.5.5 Southeast Asia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.5.6 India Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2029
6.6.2 Brazil Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.6.3 Argentina Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Revenue, 2018-2029
6.7.2 Turkey Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.7.3 Israel Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.7.4 Saudi Arabia Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
6.7.5 UAE Adult Attention Deficit and Hyperactivity Disorder Market Size, 2018-2029
7 Adult Attention Deficit and Hyperactivity Disorder Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.1.4 Takeda Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.2.4 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.3.4 Novartis Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.4.4 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Tris Pharma
7.5.1 Tris Pharma Company Summary
7.5.2 Tris Pharma Business Overview
7.5.3 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.5.4 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.5.5 Tris Pharma Key News & Latest Developments
7.6 Neos Therapeutics
7.6.1 Neos Therapeutics Company Summary
7.6.2 Neos Therapeutics Business Overview
7.6.3 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.6.4 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.6.5 Neos Therapeutics Key News & Latest Developments
7.7 Mallinckrodt
7.7.1 Mallinckrodt Company Summary
7.7.2 Mallinckrodt Business Overview
7.7.3 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.7.4 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.7.5 Mallinckrodt Key News & Latest Developments
7.8 Amneal Pharmaceuticals
7.8.1 Amneal Pharmaceuticals Company Summary
7.8.2 Amneal Pharmaceuticals Business Overview
7.8.3 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.8.4 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.8.5 Amneal Pharmaceuticals Key News & Latest Developments
7.9 Noven Pharmaceuticals
7.9.1 Noven Pharmaceuticals Company Summary
7.9.2 Noven Pharmaceuticals Business Overview
7.9.3 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.9.4 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.9.5 Noven Pharmaceuticals Key News & Latest Developments
7.10 Purdue Parma
7.10.1 Purdue Parma Company Summary
7.10.2 Purdue Parma Business Overview
7.10.3 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Major Product Offerings
7.10.4 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Revenue in Global Market (2018-2023)
7.10.5 Purdue Parma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の大人注意欠陥&多動性障害治療市場予測2023-2029：刺激薬、非刺激薬 |
| 【英語タイトル】Adult Attention Deficit and Hyperactivity Disorder Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5633 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：64 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の大人注意欠陥&多動性障害治療市場規模と予測を収録しています。・世界の大人注意欠陥&多動性障害治療市場：売上、2018年-2023年、2024年-2029年 ・世界の大人注意欠陥&多動性障害治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の大人注意欠陥&多動性障害治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「刺激薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 大人注意欠陥&多動性障害治療のグローバル主要企業は、Takeda、 Johnson & Johnson、 Novartis、 Eli Lilly、 Tris Pharma、 Neos Therapeutics、 Mallinckrodt、 Amneal Pharmaceuticals、 Noven Pharmaceuticals、 Purdue Parmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、大人注意欠陥&多動性障害治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の大人注意欠陥&多動性障害治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の大人注意欠陥&多動性障害治療市場：タイプ別市場シェア、2022年 ・刺激薬、非刺激薬 世界の大人注意欠陥&多動性障害治療市場：用途別、2018年-2023年、2024年-2029年 世界の大人注意欠陥&多動性障害治療市場：用途別市場シェア、2022年 ・病院、薬局、その他 世界の大人注意欠陥&多動性障害治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の大人注意欠陥&多動性障害治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における大人注意欠陥&多動性障害治療のグローバル売上、2018年-2023年 ・主要企業における大人注意欠陥&多動性障害治療のグローバル売上シェア、2022年 ・主要企業における大人注意欠陥&多動性障害治療のグローバル販売量、2018年-2023年 ・主要企業における大人注意欠陥&多動性障害治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Takeda、 Johnson & Johnson、 Novartis、 Eli Lilly、 Tris Pharma、 Neos Therapeutics、 Mallinckrodt、 Amneal Pharmaceuticals、 Noven Pharmaceuticals、 Purdue Parma ************************************************************* ・調査・分析レポートの概要 大人注意欠陥&多動性障害治療市場の定義 市場セグメント 世界の大人注意欠陥&多動性障害治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の大人注意欠陥&多動性障害治療市場規模 世界の大人注意欠陥&多動性障害治療市場規模：2022年 VS 2029年 世界の大人注意欠陥&多動性障害治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの大人注意欠陥&多動性障害治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の大人注意欠陥&多動性障害治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：刺激薬、非刺激薬 大人注意欠陥&多動性障害治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、薬局、その他 大人注意欠陥&多動性障害治療の用途別グローバル売上・予測 ・地域別市場分析 地域別大人注意欠陥&多動性障害治療市場規模 2022年と2029年 地域別大人注意欠陥&多動性障害治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Takeda、 Johnson & Johnson、 Novartis、 Eli Lilly、 Tris Pharma、 Neos Therapeutics、 Mallinckrodt、 Amneal Pharmaceuticals、 Noven Pharmaceuticals、 Purdue Parma ... |
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people’s behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
This report aims to provide a comprehensive presentation of the global market for Adult Attention Deficit and Hyperactivity Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Attention Deficit and Hyperactivity Disorder. This report contains market size and forecasts of Adult Attention Deficit and Hyperactivity Disorder in global, including the following market information:
Global Adult Attention Deficit and Hyperactivity Disorder Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Adult Attention Deficit and Hyperactivity Disorder market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stimulant Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adult Attention Deficit and Hyperactivity Disorder include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adult Attention Deficit and Hyperactivity Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adult Attention Deficit and Hyperactivity Disorder Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, by Type, 2022 (%)
Stimulant
Non-stimulant
Global Adult Attention Deficit and Hyperactivity Disorder Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Adult Attention Deficit and Hyperactivity Disorder Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Adult Attention Deficit and Hyperactivity Disorder Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adult Attention Deficit and Hyperactivity Disorder revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adult Attention Deficit and Hyperactivity Disorder revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adult Attention Deficit and Hyperactivity Disorder, market overview.
Chapter 2: Global Adult Attention Deficit and Hyperactivity Disorder market size in revenue.
Chapter 3: Detailed analysis of Adult Attention Deficit and Hyperactivity Disorder company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adult Attention Deficit and Hyperactivity Disorder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の大人注意欠陥&多動性障害治療市場予測2023-2029：刺激薬、非刺激薬] (コード：MMG23JU5633)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の大人注意欠陥&多動性障害治療市場予測2023-2029：刺激薬、非刺激薬]についてメールでお問い合わせ |
